PHILADELPHIA, PA--(Marketwire - May 27, 2011) - Wolters Kluwer Health today announced that
has completed the acquisition of Lexi-Comp, Inc., a leading provider of
information and clinical content for pharmacists, clinicians, and hospitals
internationally. The acquisition is the latest in a series of strategic
acquisitions Wolters Kluwer Health has made in its Clinical Solutions
as part of the company's strong focus on the point-of-care market.
Arvind Subramanian, President & CEO of Wolters Kluwer Health Clinical
said "This acquisition is very much aligned with our growth strategy of
out our strong portfolio of Clinical Decision Support (CDS) solutions to
our leadership position in the point-of-care market. This strategy will
our customers to access leading clinical content, drug information for the
retail and hospital pharmacies, and innovative mobile offerings."
Lexi-Comp provides services and content to nearly 1,500 hospitals
internationally, has more than 1,700 drug monographs and is particularly
in the area of mobile content for pharmacists and clinicians. To support
supplement effective clinician-patient interactions, Lexi-Comp also
patient medication leaflets in 19 languages. The company is headquartered
Cleveland, Ohio and has approximately 150 employees.
The intent to acquire Lexi-Comp was announced on April 27, 2011. Terms of
acquisition were not disclosed.
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of
information, business intelligence and point-of-care solutions for the
healthcare industry. Serving more than 150 countries and territories
Wolters Kluwer Health's customers include professionals, institutions and
students in medicine, nursing, allied health and pharmacy. Major brands
traditional publishers of medical and drug reference tools, journals and
textbooks, such asLippincott Williams & Wilkins; and electronic information
providers, such as Ovid®, UpToDate®, Medi-Span®, Facts &
Comparisons®, Pharmacy OneSource® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global
information services company. Wolters Kluwer has 2010 annual revenues of
billion ($4.7 billion), employs approximately 19,000 people worldwide, and
maintains operations in over 40 countries across Europe, North America,
Pacific, and Latin America.
This press release contains forward-looking statements. These statements
identified by words such as "expect", "should", "could", "shall", "will"
similar expressions. Wolters Kluwer cautions that such forward-looking
statements are qualified by certain risks and uncertainties that could
actual results and events to differ materially from what is contemplated by
forward-looking statements. Factors which could cause actual results to
from these forward-looking statements may include, without limitation,
economic conditions; conditions in the markets in which Wolters Kluwer is
engaged; behavior of customers, suppliers, and competitors; technological
developments; the implementation and execution of new ICT systems or
outsourcing; and legal, tax, and regulatory rules affecting Wolters
businesses, as well as risks related to mergers, acquisitions, and
In addition, financial risks such as currency movements, interest rate
fluctuations, liquidity, and credit risks could influence future results.
foregoing list of factors should not be construed as exhaustive. Wolters
disclaims any intention or obligation to publicly update or revise any
looking statements, whether as a result of new information, future events,
PDF version of Press Release:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Wolters Kluwer NV via Thomson Reuters ONE